FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a method for specific differentiation of dental stem cells into dopaminergic neurons.
EFFECT: invention provides developing cell applications for use in treating neurodegenerative diseases and in drugs associated with said diseases.
1 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PRODUCTION OF GABA-ergic NEURONS in vitro OF EMBRYO STEM CELLS AND APPLICATION THEREOF IN TREATING NEURAL DISORDERS | 2004 |
|
RU2380410C2 |
| METHOD FOR ISOLATION OF PLURIPOTENT STEM CELLS FROM UMBILICAL BLOOD EXPRESSING ZNF281 | 2010 |
|
RU2511417C2 |
| PRODUCTION OF TERMINAL-DIFFERENTIATED DOFAMINNERGIC NEURONES FROM EMBRIONIC HUMAN FOUNDER CELLS | 2004 |
|
RU2345133C2 |
| METHOD OF OBTAINING POPULATION OF NEURAL DIFFERENTIATION INDUCED STROMAL CELLS OF FAT TISSUE | 2008 |
|
RU2396345C1 |
| METHOD OF PRODUCTION OF INDUCED PLURIPOTENT STEM CELLS OF PATIENTS WITH DOWN SYNDROME | 2012 |
|
RU2492233C1 |
| EVALUATION METHOD OF MORPHOFUNCTIONAL STATE OF INDUCED PLURIPOTENT STEM CELLS OF PARKINSONIAN PATIENTS, WHICH ARE DIFFERENTIATED TO DOPAMINERGIC NEURONS | 2012 |
|
RU2501853C1 |
| USING MESENCHYMAL AND NEURONAL MARKER EXPRESSING STEM CELLS AND THEIR COMPOSITIONS FOR TREATING NEUROLOGICAL DISEASES (VERSIONS) | 2017 |
|
RU2742828C2 |
| CONVERSION OF SOMATIC CELLS INTO INDUCED REPROGRAMMED NEURAL STEM CELLS (IRNSC) | 2011 |
|
RU2562111C2 |
| STEM CELLS EXPRESSING MESENCHYMAL AND NEURONAL MARKERS, COMPOSITIONS THEREOF AND METHODS OF PRODUCING SAID MESENCHYMAL AND NEURONAL MARKERS | 2017 |
|
RU2741839C2 |
| METHOD FOR ASSESSING NEUROPROTECTIVE PROPERTIES OF VITRO SUBSTANCES AND THE TEST SYSTEM FOR ITS IMPLEMENTATION | 2016 |
|
RU2646446C1 |
